Barron's : There’s a Meat Shortage Coming. Tyson Foods Looks Like a Good Bet.

There’s a Meat Shortage Coming. Tyson Foods Looks Like a Good Bet.

This past week, Tyson Foods, the country’s largest meat company, warned that the coronavirus endangers the U.S. food-supply chain.

In full-page advertisements in national newspapers, John H. Tyson, the company’s chairman, warned that pork, beef, and chicken plants are being closed, removing millions of pounds of meat from the supply chain. This could create food shortages and even the mass destruction of millions of chickens, pigs, and cattle. Without processing plants, most farmers have nowhere to sell livestock.

“The food supply chain is breaking,” he wrote.

By Tuesday, President Donald Trump signed an order that used the power of the Defense Production Act to classify meat processing as a critical infrastructure. Tyson stock rallied and closed the day smartly higher, but that was of little comfort to meat plant workers.

The United Food and Commercial Workers International Union responded by asking the president for rules to protect even more workers from getting sick and dying. Tyson stock appears to be in a holding pattern ahead of its second-quarter earnings report, to be released Monday.

Tyson (ticker: TSN) is expected to earn $1.05 a share, down from $1.20 in the year-ago quarter. Estimates have declined by 27% in the past three months, likely reflecting the current difficulties and seasonal patterns. The company advised investors during its last earnings call that the second quarter is traditionally weaker than the first quarter.

Despite the worsening outlook, Tyson shares have gained about 41% since mid-March, almost double the performance of the S&P 500 index.

Tyson’s options are priced as if the stock will make an earnings-related move of about 8%, up or down, compared with an average realized move on earnings of about 4%, up or down, over the past eight quarters.

While it is tempting to speculate on Tyson’s earnings, it is difficult to confidently assert a short-term direction. What is evident is Tyson’s long-term outperformance versus the S&P 500. Since 1980, the stock has advanced 9,340%, compared with 3,186% for the index. Its performance has been bumpy the past few years, but the demand for meat hasn’t abated and is forecast to sharply increase over the next 25 years.

To position, investors can buy Tyson stock and enhance the position with a “call spread.” With the stock around $64, investors can create a call spread by buying the January $65 call option and selling the January $75 call for $4.30.

The strategy is used when investors think the associated stock will advance and they want to lower the cost of the options position, though this limits the returns. Still, spreads are popular among aggressive investors who focus on the potential to earn triple-digit gains if everything works as expected.

Should Tyson stock be at $75 at expiration, the spread’s maximum profit is $5.70.

The earnings report will provide some much-needed clarity and likely offer an opportunity to trade options and buy stock without inflated fear and greed premiums.

During the past 52 weeks, Tyson shares have ranged from $42.57 to $94.24. The stock is down 30.5% this year and 15.4% over the past 52 weeks.

The suggested strategy reflects a belief in buying good companies when the stock price is weak and the macro themes are attractive.

On Tyson’s first-quarter earnings call in early February, the company told investors that it had completed six consecutive quarters of growth, and it was making plans for an even brighter future.

The company also announced the formation of the Coalition to Advance the Future of Sustainable Protein at the World Economic Forum in Davos to address ways to feed the world. Tyson CEO Noel White said world population is estimated to reach 10 billion by 2050, requiring an estimated doubling of protein production.

Barron's : Sodexo Had Troubles Before the Pandemic. Now Its Stock Is Even Less A

Sodexo Had Troubles Before the Pandemic. Now Its Stock Is Even Less Appetizing.

French-listed caterer Sodexo, the world’s second biggest food-services group, feeds people in offices, schools, and airport lounges, and at sporting events.

Demand for these services has been hit hard as consumers eat at home in the fallout of the coronavirus crisis. Catering firms are feeling the effects more than most, and Sodexo (ticker: SW.France) is braced for an unappetizing second half.

A March report by Rabobank said that consumption of food on premises accounts for 60% to 80% of all revenues among food-service companies—and such consumption right now isn’t allowed across most of Europe.

But Sodexo had been facing hurdles before the pandemic, so there won’t be much for investors to dine out when restrictions are lifted.

The firm, which provides food for events including Royal Ascot horse racing and the Super Bowl, saw shares peak at 120.45 euros in 2017.

But by 2018, it had issued a profit warning, blaming weakness in its North America health-care and education division, and a few underperforming large contracts. It had spread itself too thinly, diversifying into noncore areas such as cleaning, security, lift maintenance, and even corporate massages. Over the past three years, shares have fallen 39.8%, to €70.36.

French investment bank Société Générale thinks the shares have further to fall, forecasting a target price 19% lower at €57. Andrew Brooke, an analyst at RBC Capital Markets, has marked the stock Underperform, with a €60 target.

“Sodexo had many issues pre-Covid-19 and was struggling with its restructuring and needed to invest,” Brooke wrote in an April note. “Covid-19 will impact materially and likely affect the time scale of the recovery.” He added that while the business has been hit hard, its valuation is not compelling, and “we are not fans of its defocused strategy.”

New CEO Denis Machuel is attempting to refocus the group by making food service a priority. Last month, Sodexo posted a 5.9% rise in underlying operating profit to €685 million ($742 million) for the six months to Feb. 29, on sales of €11.7 billion.

Machuel told Barron’s, “Our strategic agenda is working and has started to deliver results. The first half was better than we expected, with many positive signs in most segments that the underlying dynamics were improving.

“I am extremely proud of our teams’ exemplary efforts and engagement during this [coronavirus] crisis, and I am convinced that the improved momentum in this first half will help us emerge stronger than we were before.”

Sodexo fetches 18.9 times this year’s expected earnings and is valued at a 20% discount to its peers. The company is part of France’s CAC 40 index of leading stocks and has a market value of €10.1 billion.

It now employs 470,000 workers and serves 100 million consumers a day in 67 countries. Sodexo is the biggest French-based private employer in the world.

The business has some challenges to overcome. It had suffered from a dependence on a few very large clients and has been seeking to expand to more, smaller clients. Its previous strategy of diversifying into nonfood areas was seen as a distraction and a barrier to gaining more economies of scale.

While Machuel is focused on delivering strong growth, the business, along with bigger peer Compass, may never bounce back to postcrisis levels, as people become accustomed to working from home, reducing demand for on-site serviced canteens.

Sodexo’s stock is looking less gastronomique and more ordinaire.

Barrons : 10 Energy Company Bonds That Could Reward Investors

10 Energy Company Bonds That Could Reward Investors

Here is a rare chance to have an edge over Warren Buffett.

The famed investor, who addresses shareholders this weekend, appeared to have pulled off a coup a year ago. He arranged for Berkshire Hathaway (ticker: BRK.A) to buy $10 billion of Occidental Petroleum (OXY) preferred stock, with a high 8% dividend yield, to help Occidental finance its ill-fated, $57 billion acquisition of Anadarko Petroleum.

Today, investors less famous than Buffett can also get an 8% yield—on Occidental Petroleum debt—while being in a senior position to Berkshire. This debt yielded 3% to 4% earlier this year. The change follows a plunge in crude oil prices that has strained Occidental’s leveraged balance sheet, causing its credit ratings to be cut to junk status.

The bonds of Occidental and other junk-grade energy companies offer a high-yielding way to play the depressed oil and gas sector and are an alternative to battered energy stocks.

Sure, there is plenty of risk in the most leveraged, speculative oil and gas producers. The oil market has collapsed, with West Texas Intermediate trading at a recent $19 a barrel, down from $60 in January. A wave of bankruptcies is likely to build as a result.

But Barron’s has identified 10 energy companies, mostly in the upper tier of the junk market, that look like survivors and whose debt yields in the 8% to 12% range.

These issuers include Occidental, Marathon Oil (MRO), Parsley Energy (PE), and several companies in natural gas, such as EQT (EQT), Southwestern Energy (SWN), and Range Resources (RRC). Marathon still has investment-grade ratings.

“It’s not a question of whether oil prices recover, but how long it will take and which can survive and what is the opportunity set,” says Kevin Loome, portfolio manager of the T. Rowe Price U.S. High Yield fund (TUHYX).

Investors may prefer the safety of dividends from big U.S. oil and gas producers. Exxon Mobil (XOM) yields 7.6%; Chevron (CVX), 5.7%; and ConocoPhillips (COP), 4%.

“It’s not a question of whether oil prices recover, but how long it will take and who can survive and what is the opportunity set. ”

— Kevin Loome, Manager, T. Rowe Price U.S. High Yield fund
Yet these companies are borrowing to pay their dividends, with Exxon stretching its balance sheet the most. And in Europe, Royal Dutch Shell (RDS.B) surprised investors this past week by reducing its payout by two-thirds. The move highlights that dividends are discretionary. Interest payments are not.

Still, energy debt can be harder for retail investors to purchase than stocks, since the bonds trade in an over-the-counter market.

Loome sees the most value in the “higher-quality part of the high-yield space,” like Parsley Energy, whose five-year debt yields about 8%. Parsley, he says, has a strong position in the prolific Permian Basin in Texas and New Mexico and has among the lowest operating costs in that region. Energy makes up about 10% of the $1 trillion ICE BofA U.S. High Yield Index.

Occidental Petroleum is the biggest name in the junk energy market, a “fallen angel” with $38 billion of long-term debt that lost its investment-grade credit ratings in March. Two of its benchmark issues are the 3.5% unsecured bonds due in 2029, trading at about 70 cents on the dollar and yielding 8%, and the 4.4% bonds due in 2049 at 61 cents with a 7.8% yield.

The debt offers a lower-risk, high-yielding alternative to Occidental’s common stock, which is down 60% this year, to $16, and yielding 2.8% after an 86% reduction in the dividend earlier this year. The dividend could be eliminated entirely, given that Occidental is now paying the dividends on Berkshire’s preferred with common stock and not cash.

J.P. Morgan credit analyst Tarek Hamid called Occidental “incredibly asset-rich” in a note in late March. He cited its global oil and gas assets, producing one million barrels a day (Chevron and Exxon are close to four million), and a large chemical business.

The main risks are Occidental’s high debt—a legacy of the Anadarko deal—and a total of $11 billion of debt maturities for 2021 and 2022.

Bulls on the bonds argue that Occidental’s assets are sufficient to cover its debt. “Occidental has a lot of levers to pull, and we feel it can get through” the debt maturities, Loome says.

He and others also take comfort that bondholders are senior to both Buffett and activist investor Carl Icahn, who holds a 10% stake in Occidental common stock.

Hamid is partial to the debt of Western Midstream Partners (WES), a pipeline company controlled by Occidental that has natural-gas exposure. Its 5.25% bonds due in 2050 yield about 7.5%.

Natural gas has benefited from weak oil prices this year. Gas for delivery late this year and in 2021 has rallied, as investors see that reduced oil output is cutting the amount of “associated” gas that is produced with that crude.

While spot gas prices are under $2 per million British thermal units, the future price for the coming winter is about $3, and the 12-month “strip” for 2021—the average price for delivery next year—is at $2.70, up 25% this year. U.S. gas demand is holding up better than oil demand, since little gas is used for transportation and a third goes to generate electricity. Utilities are seeing relatively small drops in demand.

Most natural-gas stocks are in the black this year, with EQT, Southwestern, and Range up an average of about 25%. EQT, favored by J.P. Morgan’s Hamid, is the safest of the three, having the lowest debt ratios and production that is 95% natural gas.

With 4% of U.S. output, EQT is the largest gas producer in the country. Its 7% bonds due in 2030 trade at about 94 cents on the dollar and yield more than 9%. The interest rate on those bonds has been increased to 8.75% because of credit rating downgrades.

Range and Southwestern have higher yields, reflecting greater leverage. “Range is one of the lowest-cost gas producers, and it’s well on its way to fixing its balance sheet,” says investor Ross Margolies. “There is strong asset coverage of the debt.”

Range’s 4.875% bonds due in 2025 trade around 77 cents on the dollar and yield almost 11%.

Margolies says that Southwestern’s management team “has done a phenomenal job” in improving the company’s asset mix and that it has modest debt maturities in the coming years. Its 7.5% bonds due in 2026 trade around 89 cents on the dollar and yield 9.8%.

Continental Resources (CLR), a large oil producer in the Bakken region of North Dakota, has more than halved its capital expenditure and suspended its dividend in response to the oil-price plunge.

The company lost its investment-grade credit rating from Standard & Poor’s in March, while Moody’s affirmed its junk-grade Ba1 rating, citing “low operating costs that will support solid capital returns and cash flow coverage of debt in the stressed oil price environment.”

Continental’s 4.375% bonds due in 2028 trade around 75 cents on the dollar and yield 8.5%. Investors can take comfort that they are senior to founder Harold Hamm, who owns a 78% equity stake worth $4.2 billion.

Marathon Oil, a major oil producer in both the Bakken and the Eagle Ford area of Texas, has cut 2020 capital expenditure by nearly 50%. Its leverage is expected to rise in the coming year amid lower energy production.

But Marathon “has ample liquidity to weather the current depressed oil price environment,” Credit Suisse’s William Featherston wrote recently. Its 4.4% investment-grade bonds due in 2027 trade around 75 cents on the dollar and yield almost 9%.

Cenovus Energy (CVE), a Canadian oil sands producer and refiner, reported a large first-quarter loss this past week. It has slashed capital expenditures and cut its dividend. Lower oil prices and the wide differential of Canadian crude relative to West Texas Intermediate, the U.S. benchmark, have pressured its results.

J.P. Morgan analyst Phil Gresh recently wrote that Cenovus “highlighted some silver linings around a robust liquidity profile that should help it weather a worst-case storm.” The company believes that it can be free-cash-flow neutral with WTI crude at $38 a barrel. It has reserves of seven billion barrels of crude. Its 4.25% bonds due in 2027 appear to reflect the risks, at a price of 79 cents on the dollar and a yield of 8.3%.

Comstock Resources (CRK) has the lowest credit rating in the group, and its debt yields over 12%. Moody’s downgraded its debt to Caa2 from B3, citing weakened liquidity and low gas prices.

But Comstock has a prominent backer in billionaire Dallas Cowboys’ owner Jerry Jones, who owns a 73% equity stake worth over $1 billion. Debt investors are senior to Jones, who bought 50 million shares of stock for $300 million last summer.

The bar is lower for debt investments to work than for equity. Companies need to survive, not necessarily thrive. With these 10 energy producers, that looks like a reasonable bet.

Barron's : 10 Energy Stocks to Buy Now, According to Barron’s Experts

10 Energy Stocks to Buy Now, According to Barron’s Experts

The energy sector has been a disaster zone this year, as the coronavirus pandemic has decimated global oil demand. West Texas Intermediate, the benchmark U.S. crude, has plummeted nearly 70% to a recent $19.21 a barrel, while Brent, the most popular international benchmark, is down 60%, to $26.34. Most oil and gas producers, including the majors, will lose money in 2020 or barely eke out a profit, and most of those still paying dividends will have to borrow to cover the cost. As for energy stocks, they have made fools of their fans for nearly a decade, and now account for a measly 3% of the S&P 500 index.

Yet, the members of Barron’s 2020 Energy Roundtable see glimmers of hope for this beleaguered sector—and long-suffering investors—even though things could get worse before they get better. The painful steps that energy companies are taking to reduce supply and conserve cash are likely to pay off in higher oil and gas prices over the next two years—and stronger operations and balance sheets for the industry’s survivors. Emblematic of recent moves, Royal Dutch Shell (ticker: RDS.B) slashed its quarterly dividend on Thursday by 66%, to 16 cents a share from 47 cents, its first cut since World War II. And on Friday, Exxon Mobil (XOM) reported its first quarterly loss in decades.

Our 2020 Roundtable panelists include Phil Gresh, an energy analyst at J.P. Morgan; Bernadette Johnson, vice president of strategic analytics at Enverus, a data and analytics provider to the energy industry; Patrick Kaser, a portfolio manager specializing in large-cap value stocks at Brandywine Global; and Robert Thummel, a senior portfolio manager at Tortoise, which invests in “midstream” companies focused on energy transportation, storage, and marketing. The consensus among the group is that oil prices could double in the next year or so, to about $50 for Brent, as the global economy reopens and crude supply and demand ease back into balance.

“For companies to produce oil profitably, Brent needs to trade around $50 a barrel. ”

— Phil Gresh, J.P. Morgan
Barron’s conducted the 2020 Energy Roundtable in mid-April via Zoom, and followed up by phone with the panelists to get their read on ever-changing market conditions. Oil prices, for one, perked up last week, with June WTI futures jumping 25% on Thursday, while many energy stocks have rebounded by 40% or more from their late-March lows. Even so, our panelists consider stocks such as Chevron (CVX), ConocoPhillips (COP), Valero Energy (VLO), and Williams Cos. (WMB) compelling buys at current prices.

An edited version of the Roundtable follows.

Barron’s: These are dark days in the oil patch, and for energy investors. Let’s cut to the chase: Is there any reason to continue investing in the sector?

Patrick Kaser: There is an assumption that anyone looking to invest in energy stocks, and oil stocks in particular, is an idiot. [Laughter] That assumption appears pretty reasonable—if you’re looking in the rearview mirror. What will it take for the group to do well? Over the long term, things will normalize. In January, the industry was on a path to a pretty good environment. Brent crude was trading in the $60s. Supply and demand looked reasonably balanced, and excess capacity was lower than it generally had been in the past 30 to 40 years. We think things will get back there, but the timing is uncertain. The stocks have been destroyed. There will be survivors that come out on the other side looking stronger. Their shares are pretty attractive right now.

Phil Gresh: If you rewind the clock to December, companies with the right cost structure could thrive in a $60 Brent environment. They could cover their dividends fully. Oil companies were buying back stock with excess cash flow. They could compete with the S&P 500 on a cash-flow-yield basis—and then the oil price had a tumultuous drop.

The math doesn’t work for oil companies at current prices. For companies to produce oil profitably, Brent needs to trade around $50. At some point, the price will recover, but wiping away 25% of global demand won’t help in the short term. We believed in early April that prices had near-term downside risks. However, with demand starting to improve and U.S. exploration and production companies now aggressively shutting production, we should be near the bottom on the oil price, absent a major Covid-19 relapse.

Kaser: Shale companies can’t make money at $50 Brent and $40 WTI. The majors generally need $50-plus Brent to cover their dividends. Sovereign states that rely on oil revenue can’t balance their budgets at $50 oil. Banks won’t be willing to lend to the industry, and private-equity buyers aren’t going to step back in.

Robert Thummel: I agree, but let’s not forget the macro perspective: Energy is essential. Although demand is down right now, the world is going to need more energy in the future. Low-cost energy will help to boost the global economy.

Bernadette Johnson: The market is efficient at pricing in risk. Oil prices have collapsed twice in the past six or seven years. That would tell investors there is a greater likelihood of that happening again. If you’re an operator, this means you might require a higher return than in the past because the risk is greater. If you’re an investor, you require a higher rate of return before you’re willing to invest. Thus, when demand comes back and oil prices recover, the commodity price might be a little higher than it otherwise would have been. Maybe crude goes to $60 or $65 a barrel, instead of $50 or $55, depending on how high you need it to be to get that marginal barrel produced. Today, prices are dropping to push barrels out. Longer term, the market will also work and pull investors back into the energy space.

The May futures contract for WTI crude turned negative in April, falling below minus $37 a barrel , as demand plummeted and storage capacity ran out. How alarmed should investors be by this historic selloff, and are negative prices likely to recur?

Kaser: Investors shouldn’t be particularly alarmed at WTI going negative, nor should they be shocked if it happens again. The reality is that storage is at a premium in Cushing, Okla., and even seemingly empty storage is contracted. While people were surprised by how far below zero prices went, that seemed to be an unusual set of circumstances with open interest [open futures contracts] and perhaps some unsophisticated investors who got stuck. Low prices, including negative prices, are a catalyst for necessary production shut-ins that are happening now as production is brought down to reflect the absence of places to put it.

Gresh: Negative oil prices were an anomaly—a function of a timing mismatch between the pace of demand reduction and that of supply reduction, as well as WTI contract idiosyncrasies that reportedly caught an industry exchange-traded fund [ U.S. Oil /USO] offsides. Both issues are in the process of being resolved, with demand improving, supply shrinking, and a well-publicized change in the contract duration of this ETF’s holdings.

“The longer you knock out crude drilling …the better it is for gas prices. ”

— Bernadette Johnson, Enverus
Thummel: I don’t think prices go negative again, as financial contract holders have learned their lesson: Don’t hold financial contracts that you can’t honor as expiration approaches. Investors should keep an eye on open interest levels of front-month [June] oil contracts as we approach expiration on May 19. There will be limited-to-no storage capacity available at the delivery point for the WTI oil-futures contract [Cushing] on May 19, so holders of financial contracts will need to sell prior to expiration.

If open interest remains high as we approach expiration, then negative oil prices are possible again for a day or so. But this is all technical.

Will the recent deal between Russia and OPEC+ to cut production by nearly 10 million barrels a day, starting this month, help to rebalance the market?

ALSO READ
10 High-Yielding Energy Bonds That Are Worth a Look
Johnson: For the near term, it’s too little, too late. The cuts agreed to are starting from a base level in October 2018, when OPEC was producing at a higher level, so the effective cut is more like 7.1 million barrels. To us, the cuts negotiated for the second half of the year and extending through April 2022 are perhaps more meaningful. If you look at the forward strip [denoting the trading of monthly futures contracts], prices rose after the deal was announced. The industry is banking on the agreed-upon cuts to help speed the recovery in prices.

Kaser: I agree that the deal won’t bolster crude prices in the near term, and I’m OK with that. Some companies will disappear, and that will help get the market back into balance, setting us up for higher prices.

Gresh: We have seen a handful of bankruptcies in the U.S. oil industry, and we will see more. We could also see more consolidation by disciplined producers over time.

Johnson: We haven’t yet talked about natural gas. The longer you knock out crude drilling, and the associated gas that would have been produced, the better it is for gas prices. Demand destruction for gas-fired power has been running around 10% to 15% in the NYISO [New York Independent System Operator market], and less elsewhere. Industrial demand for gas hasn’t fallen off a cliff, and residential demand is still intact. Even liquefied-natural-gas exports are holding up pretty well. We expect gas prices to rise later this year. Gas-directed drillers in the northeastern U.S. that cut capital spending could announce they are starting to spend again.

Let’s go around the room, or in this case, Zoom, and get your oil and gas forecasts for year-end 2020 and year-end 2021.

Gresh: Brent crude will struggle to get to $40 a barrel by the end of this year. I think it will be in the $30s. But if you look out two to three years, the price has to be closer to $50 a barrel for the math to work. I expect that demand eventually will recover.

Thummel: I expect WTI to reach $35 a barrel [equivalent to $40 Brent] by the end of the year, and natural gas to trade at $3 per thousand cubic feet. Next year, crude could be back in the $50s, and domestic gas could stay in a range of $2.50 to $3 per MCF.

Johnson: WTI most likely will be around $35 at the end of 2020, and Brent will be $40-ish. We expect natural gas to trade around $4 per MCF when winter kicks in, around November. We look for an average gas price of $4 in 2021, which will support drilling. Brent crude could rise to around $55 a barrel in 2021 heading into 2022, and reach a longer-term equilibrium of $65 in late 2022 into 2023. Again, if producers needed a 15% minimum rate of return in the past to drill a well, they will probably need 20% in the future.

Kaser: A somewhat higher gas price seems reasonable by year end. I am a bit more bearish on Brent for this year, and bullish longer term. My best guess would be $35 a barrel by the end of 2020. But given the carnage we’re going to see in corporate capital expenditure and maintenance spending, plus shut-ins and production declines, Brent could trade up to the upper $60s in 24 months.

Many energy stocks are up 40% to 50% from their March lows, although they are down sharply for the year. What oil price are the majors reflecting?

Gresh: On average, the stocks are pricing in more than $50 Brent on a longer-term normalized basis, particularly given the amount of debt we see being added to balance sheets during the downturn.

“The market is telling us there are concerns about the safety of dividends.” ”

— Patrick Kaser, Brandywine Global
Can these companies squeeze their costs enough to lower the point at which they break even, based on prevailing oil prices?

Gresh: In 2014, before oil prices collapsed from $100 to $50 a barrel, the dividend-coverage break-even for many companies was around $100 a barrel. Then, they retooled and got their break-evens down to $50, on average. Recently, break-evens have come down a little more, but companies don’t have the same level of flexibility that they had when the oil price fell to $50 from $100. A lot of the actions being taken today are more transitory in nature. They can push out capital spending for six or nine months, but it is difficult to get their break-evens down from $50 a barrel to, say, $30.

Johnson: Shale producers can cut costs only so much before they can’t stay in business. In this environment, it is hard for them to get more efficient.

How are the companies you follow responding to the industry’s current crisis?

Gresh: Chevron cut its annual capital budget by 20%, to $16 billion from $20 billion. [The company said on Friday that it would cut its capex guidance by up to another $2 billion, to $14 billion.] Exxon Mobil, which had been spending to grow, reduced its annual budget to $23 billion from $33 billion. Both have reduced operating costs.

Thummel: Spending cuts by E&P companies have cascaded down to the midstream area, on which we focus. Some E&P companies have cut spending by 50%; among midstream companies, cuts have been around 30% to 40%. Plains All American Pipeline [PAA] recently announced a 30% reduction in capital spending. Several pipeline projects in the Permian Basin have been delayed because production will be lower than expected this year. Reducing capital and operating expenses is one way the sector will heal. If companies can preserve their dividends, however, they should do so.

That has gotten harder of late across the energy sector. Consider Shell’s announcement.

Thummel: We have seen a significant number of dividend cuts among more-commodity-sensitive midstream companies, chiefly those in the gathering and processing business. Dividends of the large integrated midstream companies are more secure. They came into the crisis with lower debt loads and higher dividend-coverage ratios, and generated a significant amount of cash above and beyond dividend payments. Several have dividend yields of around 9.5% or 10% that look secure.

Kaser: The market is telling us there are concerns about the safety of energy dividends. Companies such as BP [BP] and Royal Dutch Shell yield north of 10%. That isn’t a vote of confidence. Canadian Natural Resources [CNQ] yields 8.6% [the yield has since fallen to about 7%]. What happens to the dividends depends on the duration of low energy prices. Most of the majors, including Chevron and ConocoPhillips [COP], could wait a meaningful number of quarters before cutting their payouts. Exxon probably should cut, but won’t.

Gresh: On the U.S. side, at $40 Brent in 2020, we estimate that Exxon Mobil would be generating negative $2 billion of free cash flow before its $15 billion dividend obligation. The company recently issued $18 billion of debt, which could cover this shortfall, but one could definitely question how long it makes sense to do so.

Did Exxon blunder by spending so much money in the past few years on potential growth?

Gresh: The challenge for Exxon is that the financial outcomes in both of their downstream, or refining and chemicals, businesses in the past two years have been nowhere what they forecast as “normalized” in prior analyst days. These businesses had been huge cash-flow contributors that helped fund the majority of dividends. For example, as recently as 2017, they generated more than $9 billion of net income, but in 2020 we estimate they will generate less than $1 billion of net income, as they are experiencing a synchronized downturn.

Is there a chance that the energy sector will never get back to “normal?”

Kaser: There is always a chance that we never get back to normal, especially give the amount of capital that E&P companies have destroyed over time. Geopolitical turmoil is a possibility, as well, especially in the Middle East. And a technological breakthrough that changes the longer-term dynamic in favor of electric and autonomous vehicles could be a black-swan event.

Thummel: Energy companies were trying to be more disciplined in recent years and lure investors. They were starting to generate free cash flow and raise their dividends. A lot of companies were using their free cash to buy back stock. If the survivors remain disciplined, that could attract investors, once free-cash-flow yields become more competitive with those in other sectors of the S&P 500.

Kaser: I started the year incredibly bullish on the energy sector. We had one of the biggest overweights in energy stocks that you’re going to see in the value-investing space. There is an old saying among value investors: Something isn’t cheap until everyone else hates it, but it isn’t really cheap until you hate it yourself. That’s where energy stocks are now. The group has underperformed for eight of the past nine years. It is hard for investment sentiment to get more negative. That suggests potential upside.

Johnson: The world is still highly reliant on hydrocarbons. Renewable-energy sources are growing, but long-term demand for oil and natural gas is growing faster in percentage terms. We get a lot of questions about whether the shale-oil industry is dead. But unconventionals [energy extracted in nontraditional ways] are an important part of the global crude supply. Before the coronavirus pandemic, we were projecting a shortfall of crude by 2023, given that the industry was on track to make one major new crude discovery every five years. The last big one was in Guyana in 2015. Now it has missed an investment cycle. When demand recovers, there will be a need for the type and quality of crude used in refined products. Shale producers are nimble; they can add rigs quickly and bring a well online in three months or less. Yes, there will be more bankruptcies, but shale isn’t dead.

Governments seem to be getting more involved in dictating energy policy, even in the U.S. Will government involvement become a larger feature of the market in the future?

Kaser: The federal government can’t do much to curtail energy production, although there is some precedent for the Texas Railroad Commission , which regulates the state’s energy industry, to prorate production.

Time to move on to your favorite stocks. Patrick, you sold your oil-services stocks, but you’re sticking with some of the majors. What is the bull case for the major integrated companies?

Kaser: We came into the year with a meaningful weighting in oil services. We exited the group in late February, having failed to imagine what the virus’ spread from China to South Korea and beyond would mean for oil demand globally. Demand had been expected to grow by a million barrels this year, and suddenly it was instead reduced by 1.3 million. We sold our airline and cruise stocks then, as well, but we are still overweight energy producers.

It is naive for a value investor to think in a multiyear time frame, but having a longer-term perspective is one of the sins I’ve been inflicted with in my life. I expect a lot of the producers to come out stronger on the other side. We’re looking for companies that will produce attractive free cash flow if Brent gets back to the $50-to-$60-a-barrel range, have good management teams, don’t need to spend on unfinished projects, or don’t need to replace assets constantly.

Canadian Natural Resources is one of our favorite names. Operating results are going to be ugly for the next six months, but Canadian Natural has low costs, long-lived assets, and one of the best management teams in the business. We often ask management teams, if you could run another company, which would you pick? In energy, they name Canadian Natural. From an ESG [environmental, social, and corporate governance] perspective, which matters to a number of our stakeholders, Canadian oil-sands extraction has improved environmentally in the past 10 years. It isn’t on the leading edge of environmental friendliness, but it is no longer a nightmare. Canadian Natural does a good job from a social and governance perspective, relative to many peers.

The stock is trading around $13 [it has since rallied, to a recent $16.70], and it bottomed in the high $6 area. The price could double in two or three years, and even triple under some scenarios.

What else do you like?

Kaser: BP also fits these characteristics. In some ways, it was beneficial that BP was forced to limit its spending after its disastrous Macondo spill in the Gulf of Mexico in 2010. It didn’t do a lot of dumb things for a number of years. Most of its subsequent projects have come in under budget. The company reduced its capex this year by more than we would have imagined. BP has a diverse business, from gas exposure to geographies, and its trading, chemicals, and refining operations offer some offset to the rest of the business. It doesn’t have a lot of big projects on the horizon, and it has a pretty attractive break-even relative to peers. And, the company can cover its dividend. BP offers more stability than some other big oil companies, and in a wider range of industry environments.

BP is also thinking about the long-term transition away from fossil fuels, which could help it attract investors. This is generally true of the European energy companies; partly because of their shareholder base, they have a bit more flexibility philosophically to think about where they might end up in 10 to 20 years. As shareholders, we want to see economic returns, but from an ESG perspective, BP is in the upper half of the group. Outside of Macondo—a big outside—BP has one of the industry’s better environmental records. BP’s American depositary receipts are trading for $24. The stock could double in two or three years.

What could BP earn in a more normalized environment?

Kaser: BP could earn $4 a share in a really good scenario, but that involves layering on many assumptions. Last year, it earned $2.95. BP and Canadian Natural Resources are our biggest energy positions, by far. We have smaller positions in ConocoPhillips and Chevron. The theme here is companies that can generate free cash flow at lower oil prices than many of their peers. We just sold our stake in Royal Dutch Shell after reviewing the company’s cash flow and dividend security with some updated assumptions.

What would reignite your interest in oil-services stocks?

Kaser: Time is the biggest issue. Things will get worse before they get better. Oil-services stocks were pricing in hopes of improved drilling activity, but everything is going in the wrong direction for them. If the stocks were trading at hugely distressed levels, that would be an important variable, but is Schlumberger [SLB] a no-brainer at $16 a share? Not for us. If oil demand looked to be recovering in a sharp V, the stocks might be more interesting.

Phil, you’re a fan of the majors and refiners. Which names do you like?

Gresh: If I had to choose between the refiners and the majors, I would choose the refiners. The refiners look cheaper than the majors. Valero and Phillips 66 [PSX] are both trading at about a 10% free-cash-flow yield based on our 2022 normalized expectations, with less than two times net debt to Ebitda [earnings before interest, taxes, depreciation, and amortization] on this basis. The majors trade around a 6% free-cash-flow yield, with similar leverage, using $50-a-barrel Brent in 2022.

Valero is a best-in-class pure-play refiner. It offers a good combination of balance-sheet defense and cash-flow-generation offense. Physically, it has a greater percentage of capacity than other U.S. refiners on the Gulf of Mexico coast. If you think about where crude is being stockpiled, the U.S. Gulf Coast is well positioned to take advantage of price dislocations.

We think of Phillips as more of an integrated company, but without direct exposure to upstream [oil and gas extraction] activities. It has solid assets across refining and marketing, midstream, and chemicals.

What sort of earnings do you see for these companies?

Gresh: Assuming a more normalized environment, Valero could earn $5.50 a share in 2022. At a recent $64 a share, it is trading for less than 12 times normalized earnings. Phillips 66 was recently trading around $72. We estimate 2022 earnings of $6.25 a share, so the price/earnings multiple is also under 12 times. Both stocks screen attractively relative to almost any upstream company on free-cash-flow yield and balance sheets.

Will Valero and Phillips lose money this year?

Gresh: I expect Valero to lose $2 a share this year because it is cutting capacity utilization to closer to 80% from a more normal 95%, owing to Covid-19 demand impacts. Crack spreads [the difference between the price of crude and the prices of refined products] are going to be very weak in the second quarter. My 2022 estimate is similar to 2019’s earnings of $5.46 a share. If there is one company in refining, and possibly the entire energy sector, that might stay profitable this year, it would be Phillips 66. We see it earning $1.45 a share, albeit down from $8 last year.

Among producers, Canadian Natural Resources is the cheapest name in a $50-Brent world. It has a bit more balance-sheet leverage to work through, so you need a higher risk tolerance than for some other names.

Among the majors, I prefer Chevron to Exxon. On the E&P side, I like ConocoPhillips. But again, I prefer the refiners from a valuation perspective. For oil to work, refining has to work. If demand improves, refiners will benefit first. They have done a better job than producers of trying to prevent an inventory buildup. The U.S. refiners have impressed with industry discipline thus far, building less product inventory than we expected.

What are your earnings estimates for Chevron?

Gresh: We expect Chevron to lose a dollar a share this year, and earn about $3.10 in 2022. If oil returns to $60 a barrel or more, it could earn $5.50 to $5.75. The free-cash-flow yield in a $50-oil world would be roughly 6%, competitive with the overall market. In a world of $60 oil prices, that yield would be closer to 8%. With oil at $50, the balance sheet would be levered 1.5 times, which is top-tier in the oil majors.

What would get you interested in Exxon Mobil’s shares?

Gresh: I’d like to have more confidence in the downstream and chemicals businesses, which used to differentiate Exxon Mobil from competitors. The fact that normalized earnings power for those two businesses is lower than in the past has capped my upside view of the stock. Part of Exxon’s challenge is that a lot of its downstream and chemicals operations are in international markets, where profitability has been much worse than in the U.S. That is a structural challenge for Exxon, relative to the independent U.S. refiners.

Second, I’d like to have more confidence in the company’s defensive characteristics. Exxon used to be the most defensive company in the sector, whether judging by its break-even or its balance sheet. But it has taken on a fair amount of debt over the past few years. There are ways to reduce debt: For example, Exxon has an announced asset-sale program that would be fairly aggressive, but that would be difficult in the current oil-price environment. The other lever to pull would be cutting the dividend. If the oil-price downturn prolongs into 2021, we wouldn’t rule that out.

Rob, master limited partnerships have been decimated this year, resulting in supersize losses for some Tortoise funds, particularly closed-end funds such as Tortoise Energy Infrastructure [TYG] and Tortoise Midstream Energy [NTG], which were forced to sell assets to pay down debt. What happened, and is there a future for these sorts of vehicles?

Thummel: Tortoise launched closed-end funds focused on investing in MLPs in 2004. Tortoise MLP funds such as TYG and NTG have maintained leverage levels around 30% of total assets over the life of the funds. These closed-end funds are governed by the 1940 Act that requires certain amounts of asset coverage, relative to leverage. If they can’t maintain the required asset coverage, one option is to sell assets.

Our funds, and some others, were forced to sell midstream stocks, including MLPs, as asset prices plummeted. Lower leverage levels for closed-end funds is probably the wave of the future. We also manage an open-end fund, Tortoise MLP and Pipeline Fund [TORTX], that doesn’t employ leverage.

As for bringing investors back, the midstream business—transporting oil and gas from where it is produced to where it’s consumed—is essential. The large, integrated midstream companies, such as Williams Cos ., will be able to continue paying their dividends from cash flow, without becoming too leveraged.

Williams generates much of its Ebitda from transporting natural gas and natural-gas-related products. The stock yields around 9%. Cash flow will come down this year, but by far less, percentage-wise, than the stock has fallen. [Williams shares are down about 17% year to date, to a recent $19.37.] Williams owns and operates some of America’s most critical natural-gas energy infrastructure assets, including the Transcontinental Gas Pipe Line, or Transco.

Cheniere Energy [LNG] is another natural-gas-related company we like.

What is the attraction?

Thummel: The stock has been beaten up because investors have been concerned about continued global demand for liquefied natural gas. It is important that countries around the world, particularly China and India, use less coal and more natural gas to reduce carbon-dioxide emissions. That is happening in the U.S. Other countries are buying more LNG from the U.S.; Cheniere will benefit from this.

Among MLPs, Enterprise Products Partners [EPD] is a large, diversified midstream company that owns natural-gas assets and crude-oil and natural-gas-liquids infrastructure. The stock yields 10%.

The management team has been in place for decades. We have been invested in Enterprise for more than 15 years, and it has increased the dividend, or distribution, annually for at least 15 years. Leverage is low. Enterprise, too, will see declining demand in 2020, but is well positioned to participate when demand increases. And, it has adequate dividend coverage.

We also like Magellan Midstream Partners [MMP] which transports gasoline, crude oil, and jet fuel. As the economy recovers and consumers get back to work, there will be more demand for all energy commodities, and specifically gasoline. Diesel demand has remained fairly strong. Our stress tests indicate that Magellan’s dividend is secure, and its yield, around 10%, could be compelling to investors.

Occidental Petroleum [OXY] has been a controversial stock since the company’s costly acquisition of Anadarko last year. Phil, what is your view on Occidental?

Gresh: We have rated the stock Underweight since August, when the Anadarko deal closed. Back then, it traded for $45. Today, it trades for $15. Our price target is $5. Occidental took on a lot of debt to do that deal, and issued $10 billion of preferred stock to Warren Buffett . The debt was downgraded to junk status recently by several credit-rating agencies, so that could create refinancing risk.

Occidental has $11 billion to $12 billion of debt coming due in 2021 and ’22. It financed the debt at 3% to 4%, but might have to pay 10% to 12% to refinance it, according to some high-yield analysts. The company has slashed its operating and capital spending, but production could fall by double digits in 2021, which means less cash flow to pay down debt in the future. Asset sales are one lever the company is hoping to pull, but we’re waiting to see how things play out with the refinancing.

Thanks, Phil, and everyone.

>>> Barron’s Weekend Summary

Barron’s Weekend Summary: The level at which consumers ramp up spending will shape the way companies reopen and how the broader economic output plays out; Tech giants are doing well amid the pandemic, but still face hurdles down the road.
* Cover story: “The $22T US economy rests on people buying stuff; consumer spending accounts for 70 percent of total economic output. How, where, and when people choose to spend their money from here on out will shape companies’ reopening plans—and serve as a harbinger for the broader economic recovery,” though even when the country opens up again, Americans have little buffer—more than half of US households don’t have any emergency savings to tap in a crisis.
* Tech Trader: Positive on AAPL, AMZN, FB, GOOGL, MSFT: The tech giants—which are also the largest companies in the S&P 500—reported better results than expected, and should exit the crisis stronger than they entered it, but while investors breathed a sigh of relief over the first quarter, there is still turbulence ahead.
* Trader: “If Americans are slow to re-engage and consumers decide that they’re better off saving than spending, it could be a very long slog back to anything that resembles normal economic growth—throw in a virus revival, and it would be that much worse”; Positive on HPQ, JCI, NTAP, FOXA: The four value stocks could provide a good opportunity for investors to pick up depressed shares in companies likely to survive the coronavirus-induced economic pause, despite their high debt levels.
* Interview: Dana Telsey, chief executive and chief research officer at Telsey Advisory Group, talks about what retailers need to do in a post-pandemic world, which companies can make the transition, and whether it’s time for consumers to start shopping; she says having a brand, a digital and physical footprint, and cash to engage with customers really matters.
* Features: 1) Positive on CVX, COP, VLO, WMB, PSX, CNQ, BP, WMB, LNG, EPD, MMP: Barron’s Energy Roundtable participants see glimmers of hope for this beleaguered sector—and long-suffering investors—even though things could get worse before they get better, and they picked stocks that offer potential for investors at their current prices; 2) Positive on OXY, WES, CVE, EQT, CLR, MRO, RRC, CRK, SWN, PE: The bonds of Occidental and other junk-grade energy companies offer a high-yield way to play the depressed oil and gas sector and are an alternative to battered energy stocks; these ten companies have debt yields of nearly eight percent or more and look like they will survive the coronavirus pandemic; 3) As drugmakers rush to find a vaccine for the coronavirus, among the first and most challenging task for regulators will be weighing the enormous pressure to approve the next round of Covid-19 vaccines and therapies, against their role in protecting Americans from harmful drugs; 4) Positive on MSGE, MSGS: The companies built around Madison Square Garden and sports are good ways to play an eventual return to normalcy—wealthy investors still see value in landmark arenas, even as they sit empty—and a potential sale of the Knicks or the Rangers, or someone taking a minority stake, could be a catalyst for future gains; 5) These are challenging times for investors filing complaints against their brokers: The wait for a day in court is becoming longer, and the logjam is destined to get worse—a battered stock market can expose bogus products and frauds that weren’t easily spotted in good times, leading to a flood of new FINRA claims; 6) Cautious on CVNA: The company’s fans consider it the AMZN of car retailers, a surging e-commerce business that can’t be compared to bricks-and-mortal rivals, but as more of the latter adopt its “touchless” sales model, it is starting to look like just another used-car dealer.
* European Trader: Cautious on Sodexo: The French caterer, the world’s second biggest food-services company, faces a dent in demand as offices, schools, airport lounges, and sporting events empty out, but because it faced numerous problems before the pandemic, investors may not see much of a boost when restrictions are lifted.
* Emerging Markets: Argentinian president Alberto Fernandez’s “stunningly aggressive proposal for restructuring his country’s mountain of foreign debt” looks even worse than expected, and investors are bracing for big losses.
* Commodities: With US prices on track for a loss of over 69 percent so far this year, there are actions the regulators may take to help stabilize the market, but efforts may come too late, and none are without obstacles.
* Streetwise: “The combination of feverish gains and mounting anxiety is making asset allocation a challenge,” says columnist Jack Hough, who adds that despite the current turmoil, he’s not selling funds—“Valuations are high, but not a deal breaker. And there’s good news afoot.”

FT : Stumbling into May after running too fast

Stumbling into May after running too fast - Full article attached

The start of May, with a number of countries observing holidays, is being marked by a sharp retreat in global equities. This follows disappointing results from Amazon, Apple’s decision to withhold guidance for the current quarter and frosty US-China relations testing market sentiment.

Political tension between the US and China is flaring anew with President Donald Trump raising the prospect of deploying an old weapon: trade tariffs. The White House has squashed chatter of the US cancelling its debt with China, frankly the last thing the global financial system needs at this point.

Still, one of the ramifications of Covid-19 is an acceleration of the new cold war between the US and China. This year’s US presidential contest will be dominated by a China-bashing contest and upping pressure on companies that manufacture and/or sell goods and services across the Pacific.

For markets, the pressure shows up in the exchange rate. The offshore renminbi on Friday weakened 0.7 per cent to Rmb7.1269, its largest daily move since March (China along with much of Europe is observing May Day), although there are limits to such moves given the current macro backdrop.

Alan Ruskin at Deutsche Bank says “the broader US dollar uptrend has weakened with the Fed’s aggressive actions” and he suggests the renminbi can tag along. Or as he adds:

FT : How an unproven drug became a bellwether for global stocks

How an unproven drug became a bellwether for global stocks
Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis

As soon as Dr Anthony Fauci uttered the magic words, stock markets surged.

Sitting alongside Donald Trump in the Oval Office, the US government’s top infectious diseases official on Wednesday said a trial of the drug remdesivir had shown a “clear cut significant positive effect” in treating coronavirus. 

It was the first official confirmation that the antiviral treatment made by Californian drugmaker Gilead might be able to help patients recover more quickly from a disease that has killed more than 200,000 people worldwide. 

By the end of Wednesday, the S&P 500 had closed almost 2.7 per cent higher, while Gilead’s shares added roughly 6 per cent. 


The market moves underscored how data from trials of remdesivir have become a proxy for wider investor sentiment. As traders struggle to price assets while huge swaths of the global economy are shut down and unemployment is surging, they have homed in on the prospects for a treatment that might allow the world to reopen more quickly. 

In previous financial crises it would have been unthinkable for preliminary data from a single drug trial to result in a broad-based rise in stock prices. But at a time when investors have few barometers, the success or failure of one medicine has become a bellwether for the overall market.

“It’s wild to think that something like remdesivir could be a binary readout for the entire stock market,” said Brad Loncar, founder of Loncar Investments, which runs two biotech funds. 

The positive data from the remdesivir study run by the US government was accompanied by several caveats. Dr Fauci warned it was not a “knockout” trial and that the drug did not demonstrate a statistically significant impact on survival rates. Researchers say it is impossible to draw firm conclusions without first seeing the full results, which have yet to be published in a medical journal.

The choreography of Dr Fauci’s impromptu announcement this week — which was shoehorned into a scheduled event with the governor of Louisiana — was unusual. Headline results from drug trials tend to be released by the company making the medicine or the group conducting the study before full data is presented at a medical meeting and printed in a peer-reviewed publication. 

Dr Fauci said he had decided to unveil the preliminary results because he was concerned they would leak after the researchers conducting the trial were told they should move patients receiving a placebo on to Gilead’s drug. 

Concerns over the leaking of non-public information — and the potential for market manipulation — have plagued the pharma industry for years. Famously, Martha Stewart, the lifestyle guru, went to jail after being convicted of lying to investigators over the sale of shares in 2001 in ImClone, a biotech company, ahead of an unfavourable ruling by the US Food and Drug Administration. 

Dr Fauci’s announcement capped a frenzied fortnight during which markets gyrated as conflicting, unofficial information about the effectiveness of remdesivir leaked out in dribs and drabs. 

In mid-April, Stat News reported that patients were responding to the drug. The medical news website said it had obtained a copy of a video of a trial investigator at the University of Chicago — who was studying the medicine in just 125 people — saying most of her patients had been discharged. Even in the absence of detailed information or a confirmation from Gilead, the tiny snapshot of success prompted the drugmaker’s shares to rise by as much as 14 per cent while S&P 500 futures gained in after-hours trading. 

Just one week later, the World Health Organisation accidentally published a summary of the results of another trial from China, which showed patients taking the drug had not improved. On the day the Financial Times reported the results, the S&P 500 ended down having been up as much as 1.6 per cent while Gilead fell 4 per cent.

The link between broader stock prices and remdesivir data has raised concerns that investors are putting too much store in incomplete information that they do not fully understand, resulting in hype-fuelled bubbles that could burst and exacerbate market volatility. Even the most experienced biotech fund managers struggle to read complex clinical trial results at speed, and they often disagree on the magnitude of supposedly clear-cut data. 

“I pity the people . . . trying to do this based on their sketchy ability to read good information out of highly technical medical documents,” David Kelly, the chief global strategist at JPMorgan Asset Management, said. 

It would not be the first time that generalist investors, known disparagingly as “biotech tourists” by specialist fund managers, have piled in to pharmaceutical stocks only to end up losing money. The sector also attracts a large number of retail traders, who are attracted by the binary nature of trial results that can result in sharp stock price movements: it is the investment equivalent of a gambler at a casino roulette wheel who puts all their chips on black or red. 

“There are moments like this where biotech is front and centre and people who don’t know what they’re doing throw money at the sector,” said Mr Loncar. “If history is any guide, those people often get burnt.” 

Gilead, which was chaired by Donald Rumsfeld between 1997 and 2001, when he was appointed as George Bush’s defence secretary, has always been something of a political stock. Even as it has churned out revolutionary treatments that can treat viral diseases and prevent HIV, it has generated negative attention from lawmakers for charging high prices and allegedly profiting from government-funded research. 

However, Geoffrey Porges, a biotech analyst at SVB Leerink, said the current level of scrutiny directed at Gilead is “unprecedented”. He has received a constant string of calls from fund managers trying to interpret the data, in part because they see the pharma sector as a hedge against the wider market: the theory is that the price of biotech stocks with potential drugs and vaccines could still go up even if other sectors decline. 

“The virus is wagging the market back and forth,” said Stephen Dover, head of equities at Franklin Templeton, which manages $580bn of assets. “I understand the move in Gilead. I just don't understand the move in the entire market.”

He added: “Everyone is trying to become an expert on the disease. But the truth is we're not experts on the medical side . . . and that has been part of the problem.”

However, while the release of a successful treatment or vaccine might indeed allow the economy to reopen, leading to an eventual recovery in broad stock prices, pharma companies do not necessarily stand to generate significant revenues from their products — at least, not for now. 

After years of negative publicity over the price of drugs, most drugmakers have pledged to give treatments and vaccines away for free or sell them at cost price while the crisis is at its most acute. Gilead, for instance, has said it will give away 1.5m doses of remdesivir until the end of May. Given the considerable cost of developing and making a medicine, that means the company will initially lose money on its remdesivir project. 

Just as the markets closed on Friday, President Trump announced that remdesivir had received emergency regulatory approval. The FDA confirmed the news — and issued guidance warning patients that little is known about the side effects of the drug. The stock, which had been down almost 5 per cent on concerns that Gilead will not profit from the drug, climbed in after hours trading, up 1.6 per cent.

Even if Gilead does commercialise the drug, Mr Loncar predicts peak annual revenues in the “low single-digit billions” — a “blockbuster” in pharma parlance, but not a particularly lucrative one. Compare that with the increase in the company’s market capitalisation since February, when investors were first excited by the potential of remdesivir: it has risen by about $25bn. 

FT : Warren Buffett sells all stakes in US airlines

Warren Buffett sells all stakes in US airlines
Famed investor tells virtual annual meeting Berkshire Hathaway can find nothing to buy


Warren Buffet conceded on Sunday that he had got it wrong on airlines during the coronavirus pandemic and had sold Berkshire Hathaway’s entire stakes in four US carriers.

Mr Buffett told Berkshire Hathaway’s virtual annual meeting that he sold out of American Airlines, Delta Air Lines, Southwest and United Airlines in April.

 “It turns out I was wrong,” he said. “The airline business — and I may be wrong and I hope I'm wrong — I think it has changed in a very major way.”

Berkshire sold more than $6bn of stock last month related to the airline trade.

On Saturday, the doyen of the investing world conducted his popular Berkshire Hathaway annual meeting without the customary thousands of devotees. By video conference, Mr Buffett said Berkshire was worth less today because he had taken the decision to invest in airlines.

“I don't know if two or three years from now if as many people will fly as many passenger miles as they did last year,” he said.

“If the business comes back 70 or 80 per cent, the aircraft doesn’t disappear. You've got too many planes.”

Mr Buffett also said that he had decided against lending large sums as he did during the depths of the financial crisis because Berkshire was not finding enticing opportunities.

“We haven't seen anything attractive,” he said. “The Federal Reserve did the right thing and they did it very promptly and I salute them for it. But a lot of companies that needed money . . . got to finance in huge ways in the last five weeks.”

Mr Buffett said corporate chieftains and financiers owed policymakers at the US central bank a thank-you note for the speed and ferocity at which they responded to the credit market freeze in March, which at the time sidelined companies from raising needed cash.

The Fed moved swiftly to help thaw capital markets, agreeing to buy investment grade corporate bonds and exchange traded funds invested in junk credit at the same time it worked to backstop money market funds and the commercial paper market.

Those actions, Mr Buffett added, meant companies that would have in the past needed to tap Berkshire for funding have been able to secure it elsewhere. Yields on both investment grade and high yield corporate bonds have fallen from peaks hit in March when the recent market drop was at its most severe.

“We were starting to get calls,” he said, referring to companies seeking out investment. “A number of them were able to get money in the public market frankly at terms we wouldn’t have given to them.”

Companies across the globe have borrowed more than $1.1tn through bond markets in March and April, two record setting months, according to financial data provider Refinitiv. Separate figures from S&P Global Market Intelligence unit LCD showed companies had drawn down revolving credit facilities worth more than $250bn.

Nonetheless, the lack of acquisitions and preferred stock investments by Berkshire has stood out for some investors who remember the company’s actions in the fallout of the 2008 financial crisis when it invested in Goldman Sachs, General Electric and Bank of America. Those investments signalled the comfort of one of the world’s wealthiest men to invest, and for some offered a seal of approval to buy themselves. 

“Not all the opportunities will come in the first two to three months of the crisis,” James Shanahan, an analyst who follows Berkshire at Edward Jones, said. “They'll come over time and if Berkshire can't lend at terms that are favourable to them they won't put the capital to work. You can only conclude he's being patient and disciplined.”

Mr Buffett was joined at the annual meeting by vice-chairman Greg Abel, but without his usual sparring partner Charlie Munger and the 40,000-plus shareholders who normally descend on Omaha, Nebraska. Berkshire told shareholders not to attend the company’s annual meeting in person in light of the coronavirus outbreak which is known to have killed more than 200,000 people. 

The so-called Oracle of Omaha began the meeting with an hour-long history lesson, reminding his followers that the US had endured and prospered after other crises. He ran investors through the Great Depression, the Civil War and the outbreak of the Spanish flu, with a series of black-and-white slides with simple facts written in Times New Roman font. One had only four words: “Never bet against America”. Another had six: “But never — never — bet against America”.

“We faced great problems in the past,” he said. “We haven't faced this exact problem . . . but we faced tougher problems and the American miracle, the American magic has always prevailed and it will do so again.”

The company he leads has been hurt by the coronavirus pandemic, suffering a $49.7bn loss in the first quarter after its stock portfolio was hammered alongside a broad market sell-off. Berkshire’s sprawling group of subsidiaries was hampered by government lockdowns and a decline in consumption. Investment gains generated by Berkshire’s insurance arm helped lift overall operating earnings 6 per cent, the measure Mr Buffett points to as one of the best means to evaluate the group’s performance, but profits at subsidiaries involved in transport, energy and manufacturing all declined.

FT : Lebanon gripped by prime minister’s feud with bank governor

Lebanon gripped by prime minister’s feud with bank governor
International financial support at risk as leading figures fight over economic crisis

A public fight between Lebanon’s new prime minister and its once untouchable central bank governor is jeopardising the state’s efforts to secure badly needed international financial support as it grapples with the worst economic crisis in decades.

The dispute came to a head this week after prime minister Hassan Diab, a former computer science professor, had lambasted governor Riad Salame’s handling of the country’s monetary crisis. Mr Salame, the dominant figure in Lebanon’s finance sector since its civil war, hit back on Wednesday, implying that there was a political campaign to undermine him.

In an hour-long speech, Mr Salame argued that the central bank had for years propped up the government to buy time for reforms, which never came. Accusations that he was solely to blame for any monetary policy mistakes were part of a targeted “campaign” against him, Mr Salame said.

Lebanon is at a critical juncture, having defaulted on about $90bn of debt in March, and the government and the central bank need to be working together to renegotiate with bondholders and ease the crisis, economists said.

Instead, the country’s two most important men are at loggerheads, exposing the factionalism and personal animosities that have dogged Lebanese politics and blocked reform for decades. Neither responded when the Financial Times sought comment.

“I am watching . . . the whole system, throwing fireballs like in Harry Potter,” said Roy Badaro, a Lebanese economist. “I don’t know who is Harry Potter and who is Voldemort.”

On the parallel market, the value of the Lebanese pound against the dollar has fallen almost 50 per cent since late January and food prices have doubled since October. Protests have reignited and rioters torched dozens of banks earlier this week.

“[Mr Diab and Mr Salame] should be working hand in hand to do the maximum possible to salvage the country,” said Sibylle Rizk, public policy director of Kulluna Irada, a Lebanese lobby group. “But clearly the governor of the central bank is not on the same wavelength as the government."

The parliament has approved an economic rescue plan and Mr Diab and the finance minister on Friday signed a formal request for IMF support. But the failure of the central bank and the government to work together puts “at risk potential external funding and support by development partners," said Alia Moubayed, MENA chief economist at Jefferies.

The rift began this year when the new government decided to default on its foreign obligations, bankers and government officials said. Mr Salame was opposed to halting the repayments, preferring to keep using foreign reserves to pay interest to international creditors.

Instead, Mr Diab decided that Lebanon would restructure its debts and overhaul the sprawling banking sector, which the government says has accumulated $83bn of losses.

At the same time, the finance ministry pushed the governor to provide more detail on the state of the central bank’s accounts. According to two bankers and two officials, Mr Salame was slow to comply with the requests for additional disclosures and the government has now ordered independent audits.

Years of lending to the government and attracting dollars to the import-dependent economy with high interest rates, have left the central bank with “embedded losses” of $40bn, according to the government’s economic plan prepared in collaboration with the investment bank Lazard.

Mr Salame says the central bank is transparent but insists on its independence from government. As one of the world’s longest-serving central bank governors, he was credited before the current crisis with maintaining the stability of the local currency peg for two decades and using rounds of what he called “financial engineering” to shore up the country’s commercial banks.

On Wednesday, he said he always made the government aware of his plans and actions but emphasised that he was not required to ask the government’s permission. 

Mr Salame “acts like an emperor,” said one government official, who asked not be identified by name. “[Mr Diab] is a professor who wants to tell him what to do. [Mr Salame is] not going to take that.”

The prime minister, a former education minister and vice-president at Lebanon’s premier university, was catapulted into the top job in December after former prime minister Sa’ad Hariri resigned in the face of mass anti-government protests. Although Mr Diab formally sought IMF support on Friday, his government has been criticised for not moving fast enough to tackle the crisis.

Mr Salame has led the central bank since 1993, seen at least eight different prime ministers during his tenure and has rarely faced criticism from Lebanon’s political class.

“Riad Salame has all the secrets of the republic,” said one prominent executive who spoke on condition of anonymity. “In a way he’s a time-bomb for [the politicians]. The only one who doesn’t care is Diab”.